In the News

The Situation: Increased market competition, downward price pressures, and growing complexity of worldwide regulatory reporting requirements continue to challenge large pharmaceutical companies to accelerate drug development throughput and increase right-first-time regulatory submissions, without a commensurate increase in resources. While smaller organizations may adequately meet demand using desktop tools, larger organizations require holistic, integrated platforms and streamlined business processes.